Publications - WifOR Institute

Latest publications

Journal publication

Matthias Augustin, Dominik Beier, Jennifer Branner, Dennis Häckl, Regina Hampel, Thomas Kramps, Hjalmar Kurzen, Hannah Lintener, Nima Melzer, Malina Müller, Petra Staubach, Uwe Schwichtenberg, Christian Termeer, Alexander Zink, Petra Nathan, Marcus Maurer

05/2024

The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany

Method paper

Dr. Karla Hernandez-Villafuerte, Dr. Malina Müller, Prof. Dennis A. Ostwald

06/2024

Socioeconomic Burden of Main Diseases in Eight Latin American Countries

Study

Dr. Nora Albu, Mani Juneja

08/2023

Economic Footprint and R&D Footprint for Graphene Flagship

Library

Study

2018

The Global Economic Impact of Novartis

Dr. Marcus Cramer, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Natalia Benke, Nora Albu, Prof. Dr. Dennis Ostwald
Conference poster

2017

Modelling the Societal Impact of Secukinumab in Patients with Active Psoriatic Arthritis in Germany

Dr. Malina Müller, Sebastian Himmler, Prof. Dr. Dennis Ostwald, Rieke Alten
Conference poster

2017

Modelling the Social Impact of Alirocumab in Patients with Severe Hypercholesterolemia Treated with Apheresis in Germany

Dr. Malina Müller, Sebastian Himmler, F.W. Dippel, Prof. Dr. Dennis Ostwald, J Art
Conference poster

2017

Long-Term Health Benefits of Stroke Prevention with Apixaban vs. Vitamin K Antagonist Warfarin in Patients with Non-Valvular Atrial Fibrillation in Germany: A Population-Based Modelling Study

Dr. Malina Müller, Sebastian Himmler, Prof. Dr. Dennis Ostwald, Edin Basic, Eva Hradetzky
Study

2017

Employment Insurance – Costs and Benefits

Aysel Yollu-Tok, Aysel Yollu-Tok, Dr. Sandra Hofmann, Jan Philipp Hans, Werner Sesselmeier
Conference poster

2016

Including Productivity Losses in Health Economic Evaluations from a Societal Viewpoint

Dr. Malina Müller, Sebastian Himmler

Latest publications

The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany

Socioeconomic Burden of Main Diseases in Eight Latin American Countries

Economic Footprint and R&D Footprint for Graphene Flagship

Library

The Global Economic Impact of Novartis

Long-Term Health Benefits of Stroke Prevention with Apixaban vs. Vitamin K Antagonist Warfarin in Patients with Non-Valvular Atrial Fibrillation in Germany: A Population-Based Modelling Study

Employment Insurance – Costs and Benefits

Including Productivity Losses in Health Economic Evaluations from a Societal Viewpoint

Interested in our newsletter?

Interested in our newsletter?

Latest publications

The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany

Socioeconomic Burden of Main Diseases in Eight Latin American Countries

Economic Footprint and R&D Footprint for Graphene Flagship

Library

The Global Economic Impact of Novartis

Modelling the Societal Impact of Secukinumab in Patients with Active Psoriatic Arthritis in Germany

Modelling the Social Impact of Alirocumab in Patients with Severe Hypercholesterolemia Treated with Apheresis in Germany

Long-Term Health Benefits of Stroke Prevention with Apixaban vs. Vitamin K Antagonist Warfarin in Patients with Non-Valvular Atrial Fibrillation in Germany: A Population-Based Modelling Study

Employment Insurance – Costs and Benefits

Including Productivity Losses in Health Economic Evaluations from a Societal Viewpoint

Interested in our newsletter?

Interested in our newsletter?